But I believe CYP doesn't require 3D manufacturing like bone marrow derived technologies, because of the IPSC starting material, which is uniform, consistent and infinitely expandable without facing the issues of cell senescence. I believe 3D is required for bone marrow derived cells because of the senescence issues related to batch to batch inconsistencies?
CYP surpasses the need for 3D cell scaffolding, does it not?
Please correct me if I'm wrong.
- Forums
- ASX - By Stock
- Ann: Quarterly Activity Report & Appendix 4C
But I believe CYP doesn't require 3D manufacturing like bone...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.20M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10408 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 46000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10408 | 0.195 |
4 | 126276 | 0.190 |
3 | 15055 | 0.180 |
2 | 5997 | 0.175 |
1 | 50000 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 46000 | 1 |
0.210 | 60000 | 1 |
0.220 | 1875 | 1 |
0.240 | 10000 | 1 |
0.255 | 192726 | 2 |
Last trade - 10.29am 02/09/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online